About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Pipeline
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Pipeline
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
Publications
Disease Area
Hyperphosphatemia
IBS-C
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Filter
Tenapanor Treatment of Patients with Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
June 04, 2017
Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
June 04, 2017
Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice
June 04, 2017
Palatability and Physical Properties of Potassium-Binding Resin Rdx7675: Comparison with Sodium Polystyrene Sulfonate
June 04, 2017
A Common NHE3 Single-Nucleotide Polymorphism has Normal Function and Sensitivity to Regulatory Ligands
June 04, 2017
Pages:
1
2
3
4
5
6
7
8
Load More
Sorry, nothing found in this query